PHIOGEN, a biotech company developing live biotherapeutic products (LBPs) for drug-resistant and recurrent bacterial infections, is collaborating with patient research and advocacy organization Live ...
Urinary tract infection, or more commonly known as UTI, is far more common than you think. In the US, there are approximately 8.1 million visits made to doctors each year by patients experiencing ...